Conformationally restricted analogs of deoxynegamycin

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 12, 2004, Pages 3103-3107

  Raju, B ^a   Anandan, Sampathkumar ^a   Gu, Shihai ^a   Herradura, Prudencio ^a   O'Dowd, Hardwin ^a   Kim, Bum ^a   Gomez, Marcela ^a   Hackbarth, Corinne ^a   Wu, Charlotte ^a   Wang, Wen ^a   Yuan, Zhengyu ^a   White, Richard ^a   Trias, Joaquim ^a   Patel, Dinesh V ^a  

^a Vicuron Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DEOXYNEGAMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MOLECULAR PROBE; NONHUMAN; PROTEIN SYNTHESIS;

AMINO ACIDS, DIAMINO; ANIMALS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION;

ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MURINAE; NEGIBACTERIA;

EID: 2442600065     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.04.036     Document Type: Article

References (35)

1. Swartz M.N. Proc. Natl. Acad. Sci. 91:1994;2420
2. Gold H.S., Moellering R.C. N. Engl. J. Med. 335:1996;1445
3. Miesel L., Greene J., Blak T.A. Nat. Rev. Genet. 4:2003;442
4. Walsh C. Walsh C. Antibiotics: Actions, Origins, Resistance. 2003;ASM, Washington DC. and references cited therein
5. Hamada M., Takeuchi T., Kondo S., Ikeda Y., Naganawa H., Maeda K., Okami Y., Umezawa H. J. Antibiot. 23:1970;170
6. Mizuno S., Nitta K., Umezawa H. J. Antibiot. 23:1970;581
7. Mizuno S., Nitta K., Umezawa H. J. Antibiot. 23:1970;589
8. Uehara Y., Kondo S., Umezawa H., Suzukake K., Hori M. J. Antibiot. 25:1972;685
9. Uehara Y., Hori U., Umezawa H. Biochim. Biophys. Acta. 374:1974;82
10. Uehara Y., Hori U., Umezawa H. Biochem. Biophys. Acta. 447:1976;406
11. Uehara Y., Hori U., Umezawa H. Biochem. Biophys. Acta. 442:1976;251
12. Kondo S., Yamamoto H., Maeda K., Umezawa H. J. Antibiot. 24:1971;732
13. Kondo S., Iinuma K., Yoshida K., Yokose K., Ikeda Y., Shimazaki M., Umezawa H. J. Antibiot. 29:1976;208
14. Uehara Y., Hori M., Kondo S., Hamada M., Umezawa X. J. Antibiot. 29:1976;937
15. Kondo S., Yoshida K., Ikeda T., Iinuma K., Honma Y., Hamada M., Umezawa H. J. Antibiot. 30:1977;1137
16. Streicher W., Reinshagen H. Chem. Ber. 108:1975;813
17. Streicher W., Reinshagen H., Turnowsky F. J. Antibiot. 31:1978;725
18. Curran W.V., Boothe J.H. J. Antibiot. 31:1978;914
19. Cole D.C. Tetrahedron. 50:1994;9517
20. Muller A., Vogt C., Sewald N. Synthesis. 1998;837. and references cited therein
21. Mancuso A.J., Swern D. Synthesis. 1981;165
22. Burton D.J. Chem. Rev. 96:1996;1641
23. Rodriguez M., Llinaries M., Doulut S., Heitz A., Martinez J. Tetrahedron Lett. 32:1991;923
24. Donaldson W.A. Tetrahedron. 57:2001;8589
25. Shioiri T., Ninomiya K., Yamada S. J. Am. Chem. Soc. 94:1972;6203
26. Yoshimura J., Yamaura M., Suzuki T., Hashimoto H. Chem. Lett. 1983;1001
27. Ye T., McKervey M.A. Chem. Rev. 94:1994;1091
28. Palomo C., Oiarbide M., Bindi S. J. Org. Chem. 63:1998;2469
29. 2. The stereochemistry of these analogs at cyclopropane juncture cannot be assigned by NMR due to the presence of rotomers
30. Davies S.G., Ichihara O. Tetrahedron: Asymmetry. 2:1991;183
31. Rico J.G., Lindmark R.J., Rogers T.E., Bovey P.R. J. Org. Chem. 58:1993;7948
32. 5 cfu/mL
33. Inhibition of protein synthesis was measured with a cell-free transcription/translation coupled assay (E. coli S30 Extract System, Promega, Madison, WI) using pGEMbgal as a DNA template. Compounds were pre-incubated with the reaction mixture for 10 min prior to the addition of template. After 1 h incubation, ONPG was added and β-galactosidase activity was monitored at 420 nm
34. 50=2.3 mg/kg)
35. Raju B., Mortell K., Anandan S., O'Dowd H., Gao H., Gomez M., Hackbarth C., Wu C., Wang W., Yuan Z., White R., Trias J., Patel D.V. Bioorg. Med. Chem. Lett. 13:2003;2413